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Abstract
Scleritis is a severe painful inflammatory and vision-threatening disease. The purpose of this paper is to describe two 
cases of scleritis in dogs treated with immunosuppressors and monitored by ocular ultrasound. In both cases the ocular 
wall presented marked thickening and the ultrasonic exams were repeated for weeks showing progressive improvement 
allowing adjusting the dosage of the medications. In conclusion, ocular ultrasound is a useful tool in the diagnosis and 
management of scleritis in dogs.
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Resumo
A esclerite é uma doença inflamatória extremamente dolorosa e pode afetar seriamente a visão. O presente trabalho 
descreve dois casos de esclerite em cães tratados com imunossupressores e monitorados pela ultrassonografia ocular. 
Em ambos os casos, a parede ocular apresentava acentuado espessamento e as avaliações ultrassonográficas foram 
repetidas por semanas, revelando melhoria progressiva e permitindo ajustes na dosagem das medicações. Em conclusão, 
a ultrassonografia ocular é um instrumento útil no diagnóstico e tratamento da esclerite em cães.
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Scleritis is a severe, painful inflammation of the 
sclera, and is considered a vision-threatening disease 
(JABS et al., 2000; OKHRAVI et al., 2005). It may 
involve the anterior sclera, posterior sclera, or both, 
and it may also involve adjacent structures such as the 
cornea, episclera, and uvea (OKHRAVI et al., 2005). 
The posterior scleritis may be an extension of the 
anterior process (GRAHN; SANDMEYER, 2008). The 
disease is classified as primary (idiopathic immune-
mediated disease) or secondary (traumas and 
infectious diseases), focal or diffuse, and necrotizing 
or non-necrotizing (GRAHN; SANDMEYER, 2008; 
OKHRAVI et al., 2005; RAHMAN; BISWAS, 2008; 
URBANO et al., 2002).
In humans, anterior scleritis accounts for 90% 
of cases, and diffuse anterior scleritis is the most 
frequently occurring form (GRAHN; SANDMEYER, 
2008). Association with a systemic autoimmune 
disease is common (GRAHN; SANDMEYER, 
2008; JABS et al., 2000; RAHMAN; BISWAS, 2008; 
RAMSEY, 2002), with rheumatoid arthritis, a 
connective tissue disorder, being the most prevalent, 
followed by Wegener’s granulomatosis, a vasculitis 
(GRAHN; SANDMEYER, 2008; RAHMAN; 
BISWAS, 2008; RIONO; HIDAYAT; RAO, 1999; 
SMITH; MACKENSEN; ROSENBAUM, 2007). 
Bilateral scleritis occurs in 40% to 80% of cases, 
mainly in patients with concomitant systemic disease 
(BENSON et al., 1979).
Scleritis in dogs is categorized as idiopathic 
non-necrotizing, necrotizing, and is secondary to 
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trauma, infectious organisms, and surgery (GRAHN; 
SANDMEYER, 2008). The disease is considered 
immune-mediated and organ-specific, and there is 
no evidence for underlying systemic connective tissue 
disturbance (DAY; MOULD; CARTER, 2008).
Non-necrotizing scleritis is uncommon in dogs. 
Its manifestation can be unilateral or bilateral, 
characterized by a diffuse thickening of sclera and 
conjunctival and episcleral hyperemia. If it is chronic 
or very extensive, it may lead to choroiditis with retinal 
detachment and degeneration. Clinical presentation is 
very similar to diffuse episcleritis, with the exception 
of posterior scleritis and more severe inflammation. 
It is also similar to necrotizing scleritis, but collagen 
necrosis is not observed. The pathogenesis of non-
necrotizing scleritis is not completely understood 
and is assumed to be immune-mediated (GRAHN; 
SANDMEYER, 2008).
Scleral inflammation is usually suspected from the 
clinical history, and it is confirmed by observation of 
characteristic ocular signs (OKHRAVI et al., 2005; 
RAHMAN; BISWAS, 2008). Scleritis is characterized 
by edema in the episcleral and scleral tissues with 
injection of superficial and deep episcleral vessels 
(JABS et al., 2000). Clinical signs include intense 
ocular pain, decreased vision, proptosis and fundus 
abnormalities such as choroidal folds and detachment, 
cystoids macular edema, retinal detachment, optic 
neuritis (GRAHN; SANDMEYER, 2008; RAHMAN; 
BISWAS, 2008), and vitreitis (URBANO et al., 2002). 
Clinical signs can be less obvious if involvement is 
posterior (OKHRAVI et al., 2005).
Complementary exams such as ocular ultrasound 
and others are useful in establishing the diagnosis of 
cases of posterior disease (OKHRAVI et al., 2005; 
RAHMAN; BISWAS, 2008). B-mode ultrasound is the 
 most useful method in diagnosing posterior scleritis 
in humans (BENSON et al., 1979; BISWAS et al., 
1998; McCLUSKEY et al., 1999; NANDI et al., 2009; 
OKHRAVI et al., 2005; PERRI et al., 1998), with 
computed tomography scanning demonstrating it has 
no advantages to ultrasound for the diagnosis of this con- 
dition (McCLUSKEY et al., 1999; NANDI et al., 2009).
Ocular complications are frequent in posterior 
scleritis’ therefore, it is very important to establish early 
diagnosis and treatment. The management consists 
in treating the cause, controlling inflammation, and 
reducing damage to the eye (RAHMAN; BISWAS, 
2008). Topical anti-inflammatory therapy is used to 
improve comfort (GRAHN; SANDMEYER, 2008); 
however, its routine use is insufficient to control 
the disease (GRAHN; SANDMEYER, 2008; JABS 
et al., 2000; RAHMAN; BISWAS, 2008). Systemic 
medications such as nonsteroidal anti-inflammatory 
drugs, corticosteroids, and immunomodulatory 
agents are required in the majority of the cases (JABS 
et al., 2000; RAHMAN; BISWAS, 2008).
The purpose of this paper is to describe the 
importance of ocular ultrasound as a tool for diagnosis 




A 10-year-old female Dalmatian referred to the 
Ophthalmology Service of the Veterinary Hospital 
at College of Veterinary Medicine, Sao Paulo 
University, Brazil, was presented with a history of 
blindness for three days. Ophthalmic examination 
revealed bilateral ocular hyperemia and episcleral 
injection. The patient demonstrated impaired visual 
acuity with absence of the menace reflex in both 
eyes; however, direct and consensual pupillary light 
were present. Ocular discharge, pain, pruritis, and 
buphthalmia were not observed. Tear production 
(Schirmer tear test®, Ophthalmos, Sao Paulo, Brazil) 
and intraocular pressure (Tono-Pen XL®, Bio-Rad X, 
Berkeley, California, USA) measurements were within 
normal values. Retinal folds were noted in the left 
eye during the fundoscopic exam (Binocular indirect 
ophthalmoscope IO-H®, Neitz Instruments, Tokyo, 
Japan), which was suggestive of retinal detachment. 
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Ultrasound examination was performed using 
a B-mode ocular ultrasound unit (Accutome 
Ultrasound Advent A/B System; Accutome, Malvern, 
Pennsylvania, USA) with a small and round surface 
12 MHz transducer. Th e patient was treated with 
anesthetic eye drops (Anestalcon® 0,5%, Alcon Labs, 
Sao Paulo, Brazil). Acoustic gel was applied to the 
transducer, which was then gently placed to the cornea.
Th e ultrasound fi ndings (Figure 1) revealed an 
intense degree of thickening of the posterior ocular 
wall compression of the vitreous chamber an anechoic 
area behind the posterior wall, considered as sub-tenon 
fl uid; and partial retinal detachment in the left  eye 
(Figure 1a). Th ese fi ndings were suggestive of scleritis 
with retinal detachment. Axial length was 18.6 mm in 
the right eye (OD) and 18.0 mm in the left  eye (OS).
Th e patient was treated with oral prednisone (1 
mg/kg/day) and topical prednisolone acetate drops 
1% (Pred Fort®, Allergan, Sao Paulo, Brazil), in both 
eyes (OU), three times a day. Vision improved in one 
week aft er initial treatment, and ocular ultrasound 
revealed only a mild thickening, an improvement of 
Figure 1 – B-mode ocular ultrasound.of patient 1. A. Scleral 
thickening with retinal detachment (fi rst day). 
Edema in the retrobulbar space represented 
by fl uid in the tenon capsule at 7 days (B) and 
14 days follow-up (C). D. Resolution posterior 
wall thickness and curvature corresponding to 
improvement of the ultrasound fi ndings (1 year 
follow-up)
Source: (VETERINARY HOSPITAL-USP, 2014)
the posterior ocular wall, and no evidence of retinal 
detachment. Monthly ocular ultrasound evaluations 
monitored gradual improvement of posterior ocular 
wall thickness and normal curvature (Figure 1c), and 
vision was normal at this point. Aft er treatment, axial 
length was approximately 20.0 mm in OU.
Systemic steroid therapy was slowly reduced and 
discontinued aft er 3 months; oral azathioprine (1 mg/
kg/day) was initiated at this time. Topical prednisolone 
acetate drops were applied twice daily and maintained 
for six months.
Th e azathioprine dose was gradually reduced (1mg/
kg, q48h), and maintained until the last visit (one year 
aft er initial presentation). Topical prednisolone acetate 
drops 1%, were used once daily for two years. Patient 
follow-up visits showed no recurrence for four years. 
Periodic ultrasound evaluations have not indicated 
ocular changes; however, episcleral vessels remain 
mildly dilated.
Animal 2
A 7-year-old female mixed breed dog was referred to 
the Ophthalmology Service of the Veterinary Hospital 
at the College of Veterinary Medicine, Sao Paulo 
University, Brazil, presenting with buphthalmia and 
redness OU. Th e patient had suff ered from blindness 
for fi ft een days. Pruritis, sanguineous discharge, 
and blefarospasm were observed by the owners. 
Ophthalmic examination revealed lagophthalmos and 
exophthalmos in both eyes, buphthalmia in the right 
eye, and bilateral subconjunctival hemorrhage. Th ere 
was dense neovascularization in the right eye. Due to 
severe pain, tonometry was carried out at the time of 
presentation, and the anterior chamber was not visible 
because of deep corneal edema (Figure 2).
Ocular ultrasound revealed increase thickness of the 
posterior ocular wall, with marked compression of the 
vitreous chamber, resulting in complete abnormality 
of posterior wall curvature (Figure 3a and 4a). An 
echographic diagnosis of scleritis was performed. 
Th ere were mobile, point-like echoes in the vitreous 
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Figure 2 –  Photograph of OD (A) and OS (B) of patient 2. First day exhibiting 
lagophthalmos and exophthalmos OU, buphthalmia OD; deep corneal 
edema OS; bilateral subconjunctival hemorrhage
Source: (VETERINARY HOSPITAL-USP, 2014)
of the right eye (Figure 3a), which are compatible with 
infl ammatory cells and/or intraocular hemorrhage. 
Th e initial measurements of axial length were 18.0 
mm OD and 19.7 mm OS.
Initial treatment consisted of topical 1% 
prednisolone (Pred Fort®, Allergan, Sao Paulo, Brazil) 
six times daily, topical tobramicine four times daily, 
Figure 3 – B-mode ocular ultrasound patient 2 (OD). 
A. Point-like echos in vitreous correspond-
ing to infl ammatory cells and/or intraocular 
hemorrhage (1 day). B. Marked thickening of 
the posterior wall associated with fl uid in the 
tenon space. Note the irregular posterior wall 
curvature. Th e vitreous became anechoic (7 
days follow-up). C. Normal curvature and 
decrease of the thickening of the posterior 
ocular wall (30 days follow-up)
Source: (VETERINARY HOSPITAL-USP, 2014)
Figure 4 – B-mode ocular ultrasound of patient 2 (OS). 
A. Marked thickening and irregular curvature 
of the posterior wall (fi rst day). B. Improve-
ment of the posterior ocular aspect (7 days f
ollow-up). C. Posterior wall associated with 
fl uid in the tenon space (7 days follow-up). D. 
Improvement in ultrasound fi ndings (1 year 
follow-up)
Source: (VETERINARY HOSPITAL-USP, 2014)
and artifi cial tears (Vidisic® gel, Bausch & Lomb, Sao 
Paulo, Brazil) three times daily. Th e patient received 
oral prednisone (2 mg/kg/day) and enrofl oxacin (5 
mg/kg/q12h). Aft er 17 days, clinical improvement of 
ocular signs was observed; however, vision did not 
return. Th e right eye developed hypotension.
Ocular ultrasound examination repeated every two 
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weeks revealed gradual improvement of the posterior 
wall thickness and normal curvature OU. Vitreous 
was completely anechoic OD (Figure 3c).
Vision was restored in the left eye after three weeks 
of the initial treatment. The ophthalmic signs remained 
favorable, with only scleral edema and corneal 
degeneration OD. The dose of prednisone was reduced 
to (40mg/day), and azathioprine was added (1 mg/
kg/day). Topical prednisolone acetate drops 1% were 
maintained once daily. After five weeks, prednisone 
was decreased (10 mg/day), and azathioprine was 
maintained (30 mg/day). Vision has been maintained 
until the last visit, seven weeks after the onset of 
symptoms.
No ultrasound and clinical recurrence of the scleritis 
was noted and the vision remained after follow-up of 
two months with azathioprine therapy.
Discussion
Ocular ultrasound has become an essential 
technique for exploring the globe and orbit. In most 
patients, clinical examination of the eye usually 
provides enough information to reach an ophthalmic 
diagnosis (GONZALEZ; RODRIGUEZ; GARCIA, 
2001). Ultrasound has great value in identification 
and differentiation of ocular changes and also in the 
measurement of the eye and its tissues or structures 
(STERNLICHT; ALLERMANN; MUCCIOLI, 2001), 
providing additional information which allows the 
clinician to establish treatment and prognosis of many 
diseases (GONZALEZ; RODRIGUEZ; GARCIA, 2001).
In dogs, scleritis is considered an immune-
mediated, organ-specific process in which there is no 
evidence for underlying systemic connective tissue 
disease (DAY; MOULD; CARTER, 2008). Neither 
of the two patients in this report presented systemic 
alterations. Because of the limited cases reported in 
veterinary literature, it is necessary to compare this 
disease to those described in humans (DENK et al., 
2012).
Differential diagnosis may include posterior and 
anterior uveitis, Vogt-Koyanagi-Harada syndrome, 
glaucoma, intraocular tumors, and inflammatory 
orbital disorders, all of which can affect the sclera 
(BISWAS, 1998; PERRI et al., 1998). It has been 
stated that is important to distinguish nodular 
posterior scleritis from choroidal melanoma (PÉREZ-
CAMPAGNE et al., 2007). 
Diffuse thickening of the sclera, severe ocular 
pain, visual impairment, proptosis and fundus 
abnormalities such as retinal detachment as reported, 
as observed in both cases 1 and 2. Also, patient 2 
presented with severe sclera and corneal involvement, 
which corroborate cases previously described (DENK 
et al., 2012).
In the right eye of case 2, excessive point-like echoes 
in the vitreous were observed. This is probably an 
intraocular extension of scleral inflammation. After 
treatment, the vitreous became completely anechoic, 
but clinically the eye was hypotense and blind. 
Thickening of the posterior ocular wall and retinal 
detachment were observed in the ocular ultrasound. 
These findings are in agreement with previous studies 
which showed the same signs in cases of posterior 
scleritis in humans (BISWAS, 1998; MACHADO et al., 
2009; PERRI et al., 1998). To the authors’ knowledge 
there is no description of scleritis by ultrasound in 
dogs.
It is not possible to differentiate the retina-choroid-
sclera complex by ultrasound imaging, so this 
complex is termed the posterior wall (GONZALEZ; 
RODRIGUEZ; GARCIA, 2001). In both cases, due 
to the presence of fluid in the sub-tenon space, there 
was an anechoic area behind the thickened posterior 
wall, thereby causing further delimitation of the 
posterior wall.
In humans, a disease characteristic known as “T 
signal” (BISWAS, 1998; MACHADO et al., 2009; 
PERRI et al., 1998) was not evident at the time of 
presentation due to the advanced stage of intense 
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wall thickening and excessive loss of curvature of the 
posterior wall in both cases. 
As posterior wall thickness decreased, retinal 
detachment regressed, vision returned to an apparently 
normal state, and discomfort was alleviated. However, 
clinical observation showed that the right eye of patient 
2 developed hypotony and blindness. The present 
findings are consistent with ocular complications 
in necrotizing scleritis in humans, which can lead to 
retinal detachment and phthisis bulbi in some cases 
(URBANO et al., 2003).
The treatments of choice for scleritis are topical 
and systemic immunosuppressive drugs or 
immunomodulatory regimens for management 
(BISWAS, 1998; DAY; MOULD; CARTER, 2008; 
DENK et., 2012; GRAHN; SANDMEYER, 2008; 
MACHADO et al., 2009; PERRI et al., 1998). Systemic 
corticosteroids are required to provide maximal 
regression (GILGER; BENTLEY; OLLIVIER, 2007). 
In the present investigation, the association between 
systemic corticosteroids and azathioprine has 
contributed to disease control.
Once remission is established, immunosuppressive 
therapy may gradually be reduced (GRAHN; 
SANDMEYER, 2008). Despite there being no 
recurrence after treatment in some animals, most cases 
may require low-dose maintenance therapy, as reported 
in this paper. There was no recurrence of clinical signs 
or ultrasound alterations in both animals, but the 
patients were maintained with low-dose therapy.
Posterior sclera involvement was more pronounced 
in the ultrasound images as compared to that observed 
in the ophthalmic examination of the anterior sclera. In 
both animals no biopsy was performed the diagnosis 
was clinical, ultrasound and therapeutic. Thus, scleritis 
is not classified as granulomatous because this is a 
histopathologic characterization, so it is more concise 
to classify these cases as they were manifested, as diffuse 
scleritis. The nomenclature “posterior scleritis” has not 
been described in dogs, but as the posterior sclera was 
markedly affected, this could be suited to the present 
cases. Moreover, the ultrasound findings are similar 
to those described in the human literature regarding 
posterior scleritis (BISWAS, 1998; MACHADO et al., 
2009; OKHRAVI et al., 2005; PERRI et al., 1998), but 
more exacerbated.
Conclusion
Scleritis is an ocular disease that can result in visual 
impairment. Therefore, it is emphasized the important 
contribution of ophthalmic ultrasound in providing 
a rapid and accurate diagnosis, which facilitates 
early treatment and avoids visual complications. The 
method provided a satisfactory approach to monitor 
the disease and contribute to positive outcomes of 
both cases reported. In conclusion, ocular ultrasound 
is a useful tool in the diagnosis and management of 
scleritis in dogs.
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